GLP-1 and Psychiatric Risk, Liver-Heart Links, and a New Hepatitis B Pill

Today we cover a large cohort study linking GLP-1 receptor agonists to fewer psychiatric crises in people with schizophrenia and diabetes, a Circulation review on how liver disease affects the heart, and early trial results for a new hepatitis B drug. We also look at adult ADHD, a national survey showing one in six American teens has moderate or severe anxiety, and a global policy roadmap for osteoarthritis. A quick rundown covers several more studies in immunology, sports nutrition, and joint disease.